简介：

简介：Inthecomingyearslifeexpectancyisexpectedtoincreaseandwiththisthepercentageofthepopulationaboveage65willgrow.Patientsabove65makeupmorethantwothirdsofthosecurrentlydiagnosedwithgastrointestinalmalignancies.Availableevidencebasedmedicinedoesnotfocusontheaveragepatient,abovetheage70,encounteredineverydaypractice.Mostguidelinesandclinicaltrialsarenotdesignedtotakeintoaccountthespecialconsiderationsneededwhentreatingtheelderlysuchasfunctionalstatus,comorbidities,polypharmacy,lifeexpectancy,andsocialsupport.Themajorityofavailabledataisbasedonretrospectivereviewsorsubsetanalysesoflargerstudieswheretheelderlyrepresentafractionofthestudiedpopulation.Thisreviewfocusesonthetoxicitiesandtolerabilityofcurrentstandardtherapiesfornoncolorectalgastrointestinalmalignancies,includinggastroesophageal,pancreatic,bileductandhepatocellularcancersintheelderly.Withcarefulpatientselectionandgeriatricassessmenttheelderlycansafelybenefitfromstandardtherapiesofferedtoyoungerpatients.

简介：Longnon-codingRNAs(lncRNAs)refertoagroupofRNAsthatareusuallymorethan200nucleotidesandarenotinvolvedinproteingeneration.Instead,lncRNAsareinvolvedindifferentregulatoryprocesses,suchasregulationofgeneexpression.DifferentlncRNAsexistthroughoutthegenome.LncRNAsarealsoknownfortheirrolesindifferenthumandiseasessuchascancer.HOTAIRisanlncRNAthatplaysaroleasanoncogenicmoleculeindifferentcancercells,suchasbreast,gastric,colorectal,andcervicalcancercells.Therefore,HOTAIRexpressionlevelisapotentialbiomarkerfordiagnosticandtherapeuticpurposesinseveralcancers.ThisRNAtakespartinepigeneticregulationofgenesandplaysanimportantroleindifferentcellularpathwaysbyinteractingwithPolycombRepressiveComplex2(PRC2).Inthisreview,wedescribethemolecularfunctionandregulationofHOTAIRanditsroleindifferenttypesofcancers.

简介：尽管非小的细胞肺癌症(NSCLC)能转移到几乎任何东西器官，到有重要临床的表明的胆囊的转移是相对稀罕的。这里，我们报导作为尖锐胆汁介绍的NSCLC的胆囊转移的一个案例。在恰好上面的象限和发烧疼痛地介绍的一个79岁的人。胸和腹部的计算断层摄影术(CT)扫描在胆囊变厚的肺和不规则的墙的恰好更低的脑叶显示出一个cavitary团。肺团的开的胆囊炎和针活体检视被执行。胆囊的组织学的检查揭示了显示象针活体检视估计的肺团的一样的形态学的中等区分的有鳞的房间癌。胆囊和肺织物的随后的immunohistochemical检查证明肿瘤房间为P63是积极的但是为cytokeratin否定7，cytokeratin20并且甲状腺抄写factor-1。胆囊的第二个主要肿瘤被immunohistochemical方法排除，并且最后的病理学的诊断是NSCLC的胆囊转移。尽管发生是极其稀罕的，尖锐胆汁能与肺癌症转移联合发生到胆囊。

简介：Non-parasitichepaticcystswithbiliarycommunicationarerare.Theclinicalsymptomsinvolvedarenotspecifictothiscondition,therebymakingdiagnosisdifficultandtreatmentcontroversial.Here,wereportacaseof70-year-oldwomancomplainingofabdominalsatiety,combinedwithnon-specificpainintherightupperquadrant.Theabdominalcontrast-enhancedMRI-scanrevealedalargeandthick-walledseptuscysticlesionintheliver.Duringoperation,thebiliaryfistulawasconfirmedinthecystcavity.Asilicageltubewasinsertedviathecysticductforcholangiography,whichdemonstratedcommunicationbetweenthecystandbiliarytract.Weperformedwide-scalecystwallresection;thebiliaryfistulawascompletelyrepairedbytheclosureofcommunicatedbileducts.Thepostoperativecoursewasuneventful,andthepatientwasdischargedwithnosignofcholangitisoranyothersymptoms.Thenovelsurgicalmanagementviawideresectionofthecystwallandclosureofbiliarycommunicationprovedtobeanadequateandeffectiveprocedurefortreatingnonparasitichepaticcystswithbiliarycommunication.

简介：Lungcancerrepresentstheleadingcauseofcancerdeathsinhuman.Non-smallcelllungcancer(NSCLC)accountsforabout75%--85%ofalllungcancersandcanbesurgicallyresectedinonly30%--40%ofpatientswithlimiteddisease.[1’21Theremainingpatients,withlocallyadvancedormetasta...

简介：FromJanuary1989toJuly1992,70patientsAcceptedforpublication.October23,1998CorrespondencetofXUGuang-chuan;DepartmentofOncology,TumorHospital,SunYat-SenUniversityofMedicalSciences,No.651,DongFengEastRoad,Guangzhou510060,China,Faxf(0086-20)-87761547;Phon...

简介：Objective:Toinvestigatephospho-(-cateninexpressioninnon-smallcelllungcancer(NSCLC)andtostudytherelationshipbetweenphospho-(-cateninexpressionandsomeclinicalpathologicalfactors.Methods:Theexpressionofphospho-(-cateninin67primaryNSCLCcasesdetectedimmunohistochemically.Results:phospho-(-cateninwasnotexpressedinnormalbronchialmucouscellandshowedcytoplasmicandnuclearexpressioninNSCLCcell.Totalpositiveexpressionratereached62.7%,andpositiveexpressionrateofnucleuswas38.8%.Thepositiveexpressionrate(87.5%)andnuclearexpressionrateofadenocarcinoma(62.5%)wereapparentlyhigherthanthoseofsquamouscellcancer(40.0%and17.1%)(P<0.01).Expressionofphospho-(-cateninhadnorelationshiptodifferentiationdegreeandlymphaticmetastasis.Thepostoperativesurvivaltimeisnotrelatedtophospho-(-cateninexpression.(Log-ranktest,P=0.9198;P=0.6274).COXmodelanalysisshowedthattumorstageanddifferentiationareindependentriskfactorstoprognosis(P=0.001;P=0.020).Conclusion:NSCLCcellsshowpositiveexpressionofphospho-(-catenin,phospho-(-cateninnuclearexpressionisrelevanttohistologicaltypes.Thereisnodifferenceinpostoperativesurvivaltimebetweenpatientswithphospho-(-cateninpositiveexpressionandpatientswithnegativeexpression,expressionofphospho-(-cateninisnotindependentriskfactortoprognosis.

简介：BetweenJanuary1985andJuly1987,1,622cancerpatientswereevaluatedtooutlinethepossibleapplicationsandlimitsofvariousinvestigativetechniquesforevaluatingmetastases.Seventy-threecaseswithsuperficialmetastasesofthedermal-hypodermal(59)layers,ofthemuscles(11)andofothertargetorgans(3)wereincludedinthestudy.Althoughnon-glandularsuperficialmetastasesarearelativelyrareoccurrence,diagnosticimagingtechniquesareindicatedforevaluatingtheirextentandanatomicalconnections.Secondaryneoplasmswerestudiedusingtheimagingtechniquesofsono-graphy,computedtomographyandxeroradiography.Thediagnosticreliabilityofthesethreetechniqueswasevaluated,takingintoaccounttheirabilitytodeterminetheextentofmetastasesandofassessingmalignancy.Sonographyisconsideredasasatisfactoryscreeningtechnique,butCTisanevenbettertoolforevaluatingtheextentandanatomicalconnectionsofsuchlesions.Xeroradiographyhasbeenmadeobsoleteb

简介：Lymphomararelyoccursduringpregnancy,makingthisconditiondifficulttodefine.Lymphomasthatoccurinreproductiveorgansduringpregnancyexhibituniqueclinicalcharacteristics.Amongthelimitedcases,non-Hodgkin'slymphoma(NHL)showsaconsiderablyhigherincidenceratethanHodgkin'slymphoma(HL);NHLalsodisplaysclinicalcharacteristics,suchashighaggressiveness,advancedstage,andpooroutcome.Thisstudyreportsonfourcasesoflymphomasinnon-gonadalorgans(HL,n=2;NHL,n=2)duringpregnancy.Thetumorsrapidlyprogressedinallpatientsduringpregnancybutremittedattheendofpregnancyand/ortherapy.ThetwoHLcaseswerenodularsclerosisclassicalHLandtreatedwithchemotherapyafterterminatingthepregnancy.OneoftheNHLcaseswasprimarycutaneousfollicularcenterlymphoma,aBcell-derivedindolentlymphoma.Thepatientwasfollowedupwithoutanytherapyafterterminatingherpregnancy.Theothercasewasafollicularlymphomagrade3B,whichwastreatedwithchemotherapyafterdelivery.Wealsoconductedaliteraturereviewof165lymphomacasesoccurringduringpregnancyreportedfrom1976to2013torevealthecorrelationbetweenpregnancyandlymphomaprogression.Immunohistochemistrystudieswereperformedtodeterminetheexpressionofestrogen/progesteronereceptors(ER/PR),andERwasweaklypositiveandsporadic.Weconcludedthatlymphomasoccurringduringpregnancyshouldbemanagedwithapromptandreasonabletreatment.Highestrogenlevelinmaternalbodymayaffectlymphomaprogression.

简介：

简介：Purpose:Anumberofdifferentclinicalcharacteristicshavebeenreportedtosinglycorrelatewiththerapeuticactivityofepidermalgrowthfactorreceptor(EGFR)tyrosinekinaseinhibitors(TKIs)inadvancednon-small-celllungcancer(NSCLC).Thisstudyaimedtoidentifypredictivefactorsassociatedwithprognosticbenefitsofgefitinib.Patientsandmethods:EGFRgenetypingin33advancedNSCLCpatientsreceivedgefitinib(250mg/day)wereanalyzedwithmutant-enrichedPCRassay.Gefitinibresponsewasevaluatedwithpotentialpredictivefactorsretrospectively.Results:Theoverallobjectiveresponserate(ORR)andmedianprogression-freesurvival(PFS)inthe33patientstreatedbygefitinibwere45.5%and3.0(2.0-4.0)months.TheORRandmedianPFSinEGFRgenemutationpatientsweresignificantlyhigher/longerthanthoseinEGFRgenewild-typepatients(P<0.01).Similarly,theORRandmedianPFSinnon-smokerpatientsweresignificantlyhigher/longerthanthoseinsmokerpatients(P<0.05,P<0.01,respectively).However,nodifferenceforORRandmedianPFSoccurredbetweenmaleandfemalepatients.LogisticmultivariateanalysisshowedthatonlyEGFRmutatedgenewassignificantlyassociatedwiththeORR(P<0.01).BothEGFRmutatedgeneandnon-smokerwerethemajorfactorsthatcontributedtoPFS(P<0.05).Conclusions:EGFRmutatedgeneandnon-smokerstatusarepotentialpredictorsforgefitinibresponseinNSCLCpatients.

简介：Objective:Toidentifydifferentiallyexpressedlongnon-codingRNAs(lncRNAs)involvedinthemetastasisofepithelialovariancancer.Methods:AninvitroinvasionassaywasperformedtovalidatetheinvasivecapabilityofSKOV3andSKOV3.ip1celllines.TotalRNAwasthenextracted,andmicroarrayanalysiswasperformed.Moreover,ninelncRNAswereselectedforvalidationusingRT-qPCR.Results:ComparedwiththeSKOV3cells,theSKOV3.ip1cellssignificantlyimprovedintheinvitroinvasiveactivity.Ofthe4,956lncRNAsdetectedinthemicroarray,583and578lncRNAswereupregulatedanddownregulated,respectively,inSKOV3.ip1cells,comparedwiththeparentalSKOV3cells.SevenoftheanalyzedlncRNAs(MALAT1,H19,UCA1,CCAT1,LOC645249,LOC100128881,andLOC100292680)confirmedthederegulationfoundbymicroarrayanalysis.Conclusion:LncRNAsclustersweredifferentiallyexpressedinovariancancercellswithvaryingmetastaticpotentials.ThisresultindicatesthatsomelncRNAsmightexertapartialorkeyroleinepithelialovariancancermetastasis.FurtherstudiesshouldbeconductedtodeterminetherolesoftheselncRNAsinovariancancermetastasis.

简介：客观尽管翻斗车上的许多临床的研究在非小的房间肺癌症的淋巴的转移被报导了，为淋巴的转移仍然是的翻斗车的风险因素争吵并且可争辩。这研究调查了，由multivariate逻辑回归分析，到在非小的房间肺癌症(NSCLC)的mediastinal淋巴节点(N2)的翻斗车转移的临床的特征病人。我们收集了在福建医药大学联合医院里加全身的淋巴节点解剖经历了叶切除术的256个pN2-NSCLC病人的clinicopathological数据的方法。在现在的学习的案例被划分成二个组：翻斗车转移(N2skip+)并且非--翻斗车转移(N2翻斗车)。二个组的临床的病理学的特征的回顾的分析被执行。决定一个独立因素，multivariate逻辑回归分析被用来识别可能的风险因素。256个pN2-NSCLC病人全部的结果A被招募。分析结果证明那性，病理学的类型，手术，肋膜的参与，吸烟历史，年龄，肿瘤阶段，和区别不是在pN2-NSCLC影响翻斗车转移的统计重要因素(P>0.05)，而肿瘤尺寸是为翻斗车转移(P=0.02)的一个独立因素。结论淋巴的转移在pN2-NSCLC病人增加的翻斗车的率，在里面与一种增加的肿瘤尺寸伴随。

简介：Effectsoftwodosesoftheanti-diabeticdrug,metformin(MF),onhormonalandmetaboliclevelsofserumofnon-diabeticmaleWistarratswith1,2-dimethylhydrazine(DMH)-inducedcolontumoradenocarcinomaswerestudied.Carcinogenesisintheanimalswasalsoobserved.RatswithDMH-inducedcolonadenocarcinomashadelevatedlevelsofserumglucose,insulin,insulinlikegrowthfactor-1,totalcholesterol,triglycerides,catalase,malonicdialdehyde,glycatedhemoglobin,aspartateaminotransferase,andalanineaminotransferaseanddecreasedhemoglobin.TreatmentwithtwodosesofMFnormalizedmajorityofthesechangesinDMH-treatedrats,whereasthedrugwasineffectiveinratswithoutDMHtreatment.TheonlyexceptionwasthedecreasedtriglyceridelevelsinMF-treatedrats.A100mg/kgdoseofMFincreasedDMH-inducedexophyticcoloncarcinomasanddecreasedendophytictumorscomparedwithuntreatedrats.Moreover,bothMFdosesincreasedDMH-inducedandhighlydifferentiatedtumorsanddecreasedtheinvasivenessofcoloncarcinomascomparedwithratsprovidedwithDMHandwater.Therefore,effectsofMFonmetabolichomeostasisarecriticalforpreventingcoloncancer.

简介：

简介：Objective:Anti-angiogenicdrugsareanemergingtreatmentoptionagainstmalignanttumors.Theaimofthisstudywastodeterminewhethertheadditionofperioperativerh-endostatintochemotherapycouldimprovetheprobabilityofdistantmetastasis-freesurvival(DMFS)andoverallsurvival(OS)inpatientsnewlydiagnosedwithnon-metastaticconventionalosteosarcoma.Methods:Thiswasacontrollednon-randomizedclinicalstudythatincluded388patientswithoutclinicallydetectablemetastaticdiseaseenrolledfromJanuary2008toApril2012.Thecontroltreatmentgrouphad272patients;180weremaleand92,female,withamedianageof17years.Thetreatmentgrouphad58patients;36weremaleand22,female,withamedianageof16years.Thecontrolgroupreceivedpreoperativechemotherapyfollowedbysurgeryandpostoperativechemotherapy.Thetreatmentgroupreceived4cyclesofrh-endostatinperioperativelyinadditiontochemotherapyasperthecontrolgroup.Patientswerefollowedupfrom6-101monthswithamedianfollow-upperiodof50.2months.Results:The5-yearDMFSofthecontrolgroup(61%)wassignificantlylowerthanthatoftherh-endostatingroup(79%)(P=0.013).The5-yearOSofthecontrolgroup(74%)wassignificantlylowerthanthatoftherh-endostatintreatmentgroup(87%)(P=0.029).Nodifferenceinadversedrugreactionswasfoundbetweenthese2groups.Conclusions:Theadditionofperioperativerh-endostatintochemotherapycouldsignificantlyimprovetheDMFSandOSofpatientswithnon-metastaticosteosarcoma.

简介：客观：为了改进倔强的脸中部的外部T房间non-Hodgkin鈥檚的功效，有L天门冬氨酰胺酶(LASP)的淋巴瘤(MPTC-NHL)基于抢救化疗。方法：有倔强的MPTC-NHL的21个病人被分析，11patients(LASP组)收到了L天门冬氨酰胺酶基于的抢救化疗由L天门冬氨酰胺酶，长春新碱和dexame-thosone组成。没有L天门冬氨酰胺酶，10个病人(控制组)收到了抢救联合化疗。结果：完全的宽恕率为LASP组是45.6%，0.0%为控制组织(P<0.05)。全面反应率(CR+PR)为LASP组是63.6%，10.0%为控制组织，分别地(P<0.05)。2年的幸存率为LASP组是45.5%，0.0%为控制组织(P<0.05)。LASP的主要不利效果是白细胞减少，浆液bilirubin和多糖症的举起。结论：LASP基于的初步的临床的学习表演抢救化疗可以与倔强的MPTC-NHL改进反应率和病人的2年的幸存率。进一步继续学习是必要的。

简介：

简介：客观：与非小的肺癌症(NSCLC)在病人的预后上在MRP基因overexpression的效果上学习。方法：从NSCLC的47个盒子的嵌入石蜡的纸巾经历了激进的肿瘤切除术的人，用探针与immunohistochemistry相结合的标记的digoxigenin为MRP基因mRNAbyinsitu杂交的表示被检查。所有病人是回顾地跟随起来的。结果：47个肺癌症标本的AU被发现有MRP基因mRNA的overexpression。它显著地在外科以后与病人鈥?幸存时间，对化疗的反应，复发或转移被相关，但是没与组织学，肿瘤尺寸，节点地位，TNM阶段，区别的度，年龄和性别被相关。结论：MRP基因的Overexpression是在有NSCLC的病人的预示的意义的一个标记。